Workflow
Cynda(603086)
icon
Search documents
先达股份:关于完成工商变更登记的公告
2023-09-11 07:36
山东先达农化股份有限公司 关于完成工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 山东先达农化股份有限公司(以下简称"公司")于 2023 年 6 月 29 日召开 2023 年第一次临时股东大会,审议通过了《关于回购注销 2020 年限制性股票激 励计划部分限制性股票并调整回购价格的议案》《关于减少注册资本暨修订公司 章程的议案》,具体内容详见公司在上海证券交易所网站及指定媒体披露的相关 公告。 公司现已完成相关工商变更登记手续,并取得滨州市行政审批服务局换发的 《营业执照》,新《营业执照》基本信息如下: 证券代码:603086 证券简称:先达股份 公告编号:2023-039 统一社会信用代码:913700007433656097 名称:山东先达农化股份有限公司 类型:股份有限公司(上市、自然人投资或控股) 住所:博兴经济开发区 法定代表人:王现全 注册资本:肆亿叁仟肆佰捌拾壹万叁仟壹佰肆拾叁元整 成立日期:2002 年 09 月 20 日 经营范围:农药原药合成、制剂复配;工业自产副产品硫酸铵、氯 ...
先达股份:关于延期更换选举独立董事的公告
2023-09-06 07:38
证券代码:603086 证券简称:先达股份 公告编号:2023-038 山东先达农化股份有限公司 特此公告。 山东先达农化股份有限公司董事会 2023年9月7日 关于延期更换选举独立董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 山东先达农化股份有限公司(以下简称"公司")现任独立董事仲涛先生自 2017 年 9 月 6 日起连续担任公司独立董事届满六年。根据《上市公司独立董事 管理办法》关于"独立董事每届任期与上市公司其他董事任期相同,任期届满, 可以连选连任,但是连续任职不得超过六年"的规定,公司需要更换选举独立董 事。 目前,公司正在积极筹备更换选举独立董事的相关工作,但由于公司独立董 事候选人的提名工作尚未完成,为了保持相关工作的准确性、连续性和稳定性, 公司决定延期更换选举独立董事。在公司独立董事更换选举工作完成之前,仲涛 先生将依照法律、法规和《公司章程》的规定继续履行独立董事职责和义务。公 司独立董事的延期更换选举不会影响公司董事会的正常运行。公司将在相关独立 董事提名人选确定后,尽快完成独立董 ...
先达股份(603086) - 2023 Q2 - 季度财报
2023-08-28 16:00
公司代码:603086 公司简称:先达股份 山东先达农化股份有限公司 2023 年半年度报告 1 / 154 2023 年半年度报告 重要提示 无 六、 前瞻性陈述的风险声明 √适用 □不适用 2023 年半年度报告 本报告中所涉及的未来计划、发展战略等前瞻性描述不构成公司对投资者的实质承诺,敬请 投资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况? 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、 重大风险提示 报告期内,公司不存在对生产经营产生实质性影响的特别重大风险。公司已在本报告第三节 "管理层讨论与分析"等有关章节详细描述了公司可能面临的风险,敬请投资者予以关注。 十一、 其他 □适用 √不适用 2 / 154 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、 完整性,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人王现全、主管会计工作 ...
先达股份:2023年半年度主要经营数据公告
2023-08-28 08:44
证券代码:603086 证券简称:先达股份 公告编号:2023-037 根据上海证券交易所《上市公司行业信息披露指引第十八号—化工》等相关 规定,山东先达农化股份有限公司(以下简称"公司")现将 2023 年半年度主 要经营数据披露如下(均不含税): | 产品 | 主要产品 | 2023 | 年 | 1-6 | 月产 | 2023 年 | 1-6 | 月销 | 2023 | 年 | 1-6 | 月销 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 类别 | | | 量(吨) | | | 量(吨) | | | 售金额(万元) | | | | | 除草剂 | 烯草酮系列 | | 2,761.23 | | | 2,248.10 | | | 26,328.39 | | | | | | 咪草烟系列 | | 876.99 | | | 827.18 | | | 18,283.23 | | | | | | 灭草烟系列 | | 783.07 | | | 828.63 | | | 21,098.85 | | | ...
先达股份:上海泽昌律师事务所关于山东先达农化股份有限公司2020年限制性股票激励计划回购注销部分限制性股票并调整回购价格的法律意见书
2023-08-22 10:05
上海泽昌律师事务所 法律意见书 上海泽昌律师事务所 关于山东先达农化股份有限公司 2020 年限制性股票激励计划回购注销部分限制性股票 并调整回购价格的 法律意见书 上海市浦东新区世纪大道 1589 号长泰国际金融大厦 11 层 电话:021-61913137 传真:021-61913139 邮编:200120 二零二三年六月 上海泽昌律师事务所 法律意见书 上海泽昌律师事务所 关于山东先达农化股份有限公司 2020 年限制性股票激励计划回购注销 部分限制性股票并调整回购价格的 法律意见书 泽昌证字 2023-05-05-01 致:山东先达农化股份有限公司 本所接受山东先达农化股份有限公司(以下简称"先达股份"或"公司") 委托,就公司回购注销 2020 年限制性股票激励计划部分限制性股票并调整回购 价格(以下简称"本次回购注销")相关事项出具本法律意见书。 本所及经办律师依据《中华人民共和国公司法》(以下简称"《公司法》")、 《中华人民共和国证券法》(以下简称"《证券法》")、《上市公司股权激励 管理办法》(以下简称"《管理办法》")、《律师事务所从事证券法律业务管 理办法》和《律师事务所证券法律业务执业 ...
先达股份:关于2020年限制性股票激励计划部分限制性股票回购注销实施公告
2023-08-22 10:05
证券代码:603086 证券简称:先达股份 公告编号:2023-036 本次回购注销股份的有关情况: | 回购股份数量(股) | 注销股份数量(股) | 注销日期 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 45,001 | 45,001 | | 2023 年 | 8 | 月 | 25 | 日 | 一、本次限制性股票回购注销的决策与信息披露 1、山东先达农化股份有限公司(以下简称"公司")于 2023 年 6 月 13 日召 开第四届董事会第十二次会议和第四届监事会第十二次会议,审议通过了《关于 回购注销 2020 年限制性股票激励计划部分限制性股票并调整回购价格的议案》, 公司独立董事对此发表了独立意见,上海泽昌律师事务所对本次回购注销事项出 具了法律意见书。 山东先达农化股份有限公司 关于 2020 年限制性股票激励计划部分限制性股票 回购注销实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 回购注销原因: 公 ...
先达股份(603086) - 2022 Q4 - 年度财报
2023-07-13 16:00
Financial Performance - The company's operating revenue for 2022 was CNY 3,125,923,462.62, representing a 41.92% increase compared to CNY 2,202,538,106.69 in 2021[19] - The net profit attributable to shareholders for 2022 was CNY 381,199,039.53, a significant increase of 114.90% from CNY 177,380,335.82 in the previous year[19] - The net profit after deducting non-recurring gains and losses reached CNY 420,217,141.57, marking a 178.94% increase from CNY 150,648,746.13 in 2021[19] - The net cash flow from operating activities was CNY 364,450,131.02, up 62.62% from CNY 224,108,606.00 in 2021[19] - As of the end of 2022, the net assets attributable to shareholders were CNY 2,176,337,674.88, an 18.42% increase from CNY 1,837,878,062.69 at the end of 2021[19] - The total assets at the end of 2022 amounted to CNY 3,352,809,660.06, reflecting a 23.03% increase from CNY 2,725,106,027.36 in 2021[19] - Basic earnings per share rose to 1.23 yuan, up 115.79% from 0.57 yuan in 2021[20] - The weighted average return on equity increased to 18.63%, up 8.58 percentage points from 10.05% in 2021[20] - The company's debt-to-asset ratio stood at 34.95%[27] Dividend and Shareholder Returns - The company plans to distribute a cash dividend of CNY 2.50 per 10 shares, totaling CNY 77,653,240 (including tax), with a cash dividend payout ratio of 20.37% for the year[4] - The company declared a cash dividend of 2.50 yuan per 10 shares, totaling 55.4715 million yuan distributed to shareholders[20] - The company’s cash dividend policy aims for cumulative cash distributions over three consecutive years to be no less than 30% of the average distributable profit[153] - The total amount of cash dividends distributed is CNY 55,471,500, which is consistent with the company's profit distribution policy[156] - The company declared a cash dividend of CNY 5,547,150 to shareholders, with a distribution ratio of 31.27%, marking the highest dividend ratio since its listing[185] Market and Product Development - The company is actively pursuing market expansion and technological innovation to ensure stable and healthy growth[27] - The company achieved an export revenue of $262 million in 2022, setting a new record for overseas sales[31] - The company is currently constructing a project with a production capacity of 1,000 tons of imidazolinone and 3,000 tons of pesticide intermediates, which will significantly enhance production capabilities[28] - The company has developed a patented compound, Quikazone, specifically for post-emergence treatment in sorghum fields, which has seen significant market demand and sales growth[29] - The company has launched new products targeting resistant weeds, enhancing market share and brand recognition[41] - The company is focused on developing high-end herbicides and has established a strong R&D team to drive innovation[38] - The company is committed to developing proprietary herbicides tailored to local agricultural conditions, enhancing its competitive edge in the market[110] Research and Development - The company has increased R&D investment to support high-quality development and innovation-driven strategies[29] - Research and development expenses rose to CNY 144,288,423.00, marking a 47.14% increase year-on-year[44] - The company is focusing on the research and development of innovative herbicide active ingredients and formulations, with products like imazapic and cyclohexenone leading the industry[76] - The company aims to enhance its R&D investment, focusing on developing patented herbicides tailored to China's climate and agricultural needs, with 1-2 new compounds expected to enter registration in 2023[113] Environmental and Safety Compliance - The company has implemented various pollution control facilities, including RTO regenerative thermal oxidizers and activated carbon adsorption systems, which are operating normally[176] - The company has received environmental impact assessment approvals for several projects, including a 1500 tons pesticide raw material project approved on May 30, 2022[179] - The company has established an environmental self-monitoring plan in compliance with national standards, ensuring transparency in pollutant emissions[181] - The company emphasizes the importance of employee welfare, providing timely insurance payments and enhancing working conditions[187] - The company is committed to improving safety and environmental standards through enhanced training and process optimization[126] Governance and Compliance - The company strictly adheres to the Company Law and Securities Law, ensuring compliance in governance and operations, which supports stable and healthy development[129] - The company has implemented strict information disclosure practices, ensuring that all shareholders receive fair and timely information[130] - The company has not faced any penalties from securities regulatory authorities in the past three years, reflecting compliance and governance standards[139] - The company has maintained independence from its controlling shareholders in terms of assets, personnel, finance, and business operations[131] Financial Management - The company has signed long-term procurement contracts with major suppliers to mitigate risks from raw material price fluctuations[93] - The company will implement measures to mitigate risks from raw material price fluctuations by establishing strategic partnerships with multiple suppliers[123] - The company will adopt financial hedging tools to manage foreign exchange risks associated with international sales[125] - The company has been actively seeking bank credit lines and guarantees to support its operations and growth[140] Employee and Management Structure - The total number of employees in the parent company and major subsidiaries is 1,899, with 386 in the parent company and 1,513 in subsidiaries[148] - The company has a structured salary policy that includes guaranteed, allowance, and incentive compensation levels[149] - The company has established a training plan that combines online and offline training methods to enhance employee skills and align with company development needs[151] - The company is committed to performance-based remuneration for its directors and senior management, aligning incentives with company performance[138] Strategic Initiatives - The company plans to adjust its organizational structure as part of its strategic initiatives[140] - The company is committed to building a high-quality, innovative talent team and establishing a comprehensive incentive mechanism to ensure long-term stable development[116] - The company is focusing on the domestic market, aiming to increase its share by developing innovative products to combat emerging resistant weed species[113]
先达股份:关于召开2022年度业绩暨现金分红说明会的公告
2023-05-07 07:34
证券代码:603086 证券简称:先达股份 公告编号:2023-018 山东先达农化股份有限公司 关于召开2022年度业绩暨现金分红说明会的公告 (三)召开方式:上证路演中心网络互动 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: 一、说明会类型 山东先达农化股份有限公司(以下简称"公司")已于 2023 年 04 月 26 日在 上海证券交易所网站(www.sse.com.cn)及指定信息披露媒体披露了公司 2022 年年度报告。为便于广大投资者更全面深入地了解公司 2022 年度经营成果及财 务状况,公司计划于 2023 年 05 月 15 日下午 14:00-15:00 通过网络互动形式召 开 2022 年度业绩暨现金分红说明会,就投资者普遍关注的问题进行沟通与交流, 广泛听取投资者的意见和建议。 二、说明会召开的时间、地点 (一)召开时间:2023 年 05 月 15 日下午 14:00-15:00 (二)召开地点:上证路演中心(http://roadshow.sseinfo.com/) 1 会议 ...
先达股份(603086) - 2023 Q1 - 季度财报
2023-04-25 16:00
2023 年第一季度报告 证券代码:603086 证券简称:先达股份 山东先达农化股份有限公司 2023 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,不存 在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 2023 年第一季度报告 (一)主要会计数据和财务指标 单位:元 币种:人民币 | 项目 | 本报告期 | 本报告期比上年同期增减 | | | --- | --- | --- | --- | | | | 变动幅度(%) | | | 营业收入 | 547,800,695.47 | | -2.39 | | 归属于上市公司股东的净利润 | 44,424,279.36 | | -41.36 | | 归属于上市公司股东的扣除非经常 | 35,8 ...
先达股份(603086) - 2022 Q4 - 年度财报
2023-04-25 16:00
Financial Performance - The company's operating revenue for 2022 reached CNY 3,125,923,462.62, representing a 41.92% increase compared to CNY 2,202,538,106.69 in 2021[19] - The net profit attributable to shareholders of the listed company was CNY 381,199,039.53, a significant increase of 114.90% from CNY 177,380,335.82 in the previous year[19] - The net profit after deducting non-recurring gains and losses was CNY 420,217,141.57, up 178.94% from CNY 150,648,746.13 in 2021[19] - The net cash flow from operating activities was CNY 364,450,131.02, an increase of 62.62% compared to CNY 224,108,606.00 in 2021[19] - As of the end of 2022, the net assets attributable to shareholders of the listed company were CNY 2,176,337,674.88, an 18.42% increase from CNY 1,837,878,062.69 at the end of 2021[19] - Total assets at the end of 2022 amounted to CNY 3,352,809,660.06, reflecting a 23.03% increase from CNY 2,725,106,027.36 in 2021[19] - Basic earnings per share rose to 1.23 yuan, up 115.79% from 0.57 yuan in 2021[20] - The weighted average return on equity increased to 18.63%, up 8.58 percentage points from 10.05% in 2021[20] - The cash dividend payout ratio for the year was 20.37%[4] - The company declared a cash dividend of CNY 55,471,500, which accounts for 31.27% of the net profit attributable to ordinary shareholders in the consolidated financial statements[156] Dividend Policy - The company plans to distribute a cash dividend of CNY 2.50 per 10 shares (including tax) and to increase capital by 4 shares for every 10 shares held[4] - The company has a clear and defined dividend policy that complies with the company's articles of association and shareholder resolutions[154] - The company emphasizes a stable cash dividend policy, aiming to distribute at least 10% of the net profit attributable to shareholders in cash annually[153] - The company plans to conduct cash dividends after the annual general meeting, with a goal of maintaining a cumulative distribution of at least 30% of the average distributable profit over three consecutive years[153] Research and Development - The company focuses on the research and development of high-end herbicides and has established a strong R&D team[38] - The company is committed to innovation and has established an innovation research institute to develop new compounds and technologies[38] - Research and development expenses rose to CNY 144,288,423.00, marking a 47.14% increase year-on-year[44] - The total R&D investment reached ¥161,433,327.51, accounting for 5.16% of total revenue[54] - The company is committed to increasing R&D investment to accelerate the development of differentiated herbicides tailored to the Chinese market[113] Market Expansion and Strategy - The company is actively pursuing market expansion and technological innovation to ensure sustainable growth[27] - The company is currently constructing a project with a production capacity of 1,000 tons of imidazolinone and 3,000 tons of pesticide intermediates, which will significantly enhance production capabilities[28] - The company is focusing on high-quality development and innovation-driven strategies to inject new momentum into future growth[29] - The company plans to enhance its domestic market development and reduce reliance on foreign markets, focusing on innovative products and technology-driven growth[111] Environmental Management - The company has implemented various pollution control facilities, including RTO regenerative thermal oxidizers and advanced wastewater treatment systems, which are operating normally[176] - The company has maintained effective pollution control measures, with wastewater discharge meeting standards and no environmental pollution incidents reported during the reporting period[166] - The total COD discharge was 4.03 tons, with a concentration of 91.2 mg/L, which did not exceed the permitted limits[167] - The company has received environmental impact assessment approvals for several projects, including a 1500 tons pesticide raw material project and a 3500 tons pesticide intermediate project[179] Corporate Governance - The company strictly adheres to the Company Law and Securities Law, ensuring compliance in governance and operations[129] - The board of directors and supervisory board operate in compliance with legal and regulatory requirements, ensuring effective governance[130] - The company has implemented strict information disclosure practices, ensuring that all shareholders receive fair and timely information[130] - The independent directors have fulfilled their responsibilities and played their due role in the decision-making process[154] Risk Management - The company has not identified any significant risks that could materially affect its operations during the reporting period[6] - The company is facing market competition risks due to increased supply and a downward trend in industry prices, which may impact performance[121] - The company will implement foreign exchange risk management strategies, including forward contracts, to minimize the impact of currency fluctuations on profitability[124] Employee Management - The total number of employees in the parent company and major subsidiaries is 1,899, with 386 in the parent company and 1,513 in subsidiaries[148] - The company has a structured compensation policy that links remuneration to performance, with a focus on market-oriented salary levels[149] - The company has established a training plan that combines online and offline methods to enhance employee skills and align with company development needs[151] Compliance and Auditing - The company has engaged Da Hua Accounting Firm for auditing services, with a remuneration of 550,000 RMB, and has maintained this auditor for 9 years[195] - There are no non-operating fund occupations by controlling shareholders or related parties during the reporting period[192] - The company has not reported any significant accounting errors that would require correction during the reporting period[193]